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Abstract
Persistence of hepatitis B virus (HBV) infection requires covalently closed circular (ccc)DNA formation and amplification,
which can occur via intracellular recycling of the viral polymerase-linked relaxed circular (rc) DNA genomes present in
virions. Here we reveal a fundamental difference between HBV and the related duck hepatitis B virus (DHBV) in the recycling
mechanism. Direct comparison of HBV and DHBV cccDNA amplification in cross-species transfection experiments showed
that, in the same human cell background, DHBV but not HBV rcDNA converts efficiently into cccDNA. By characterizing the
distinct forms of HBV and DHBV rcDNA accumulating in the cells we find that nuclear import, complete versus partial release
from the capsid and complete versus partial removal of the covalently bound polymerase contribute to limiting HBV
cccDNA formation; particularly, we identify genome region-selectively opened nuclear capsids as a putative novel HBV
uncoating intermediate. However, the presence in the nucleus of around 40% of completely uncoated rcDNA that lacks
most if not all of the covalently bound protein strongly suggests a major block further downstream that operates in the HBV
but not DHBV recycling pathway. In summary, our results uncover an unexpected contribution of the virus to cccDNA
formation that might help to better understand the persistence of HBV infection. Moreover, efficient DHBV cccDNA
formation in human hepatoma cells should greatly facilitate experimental identification, and possibly inhibition, of the
human cell factors involved in the process.
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Introduction
Currently, more than 350 million people suffer from chronic
HBV infection. Chronic hepatitis B frequently progresses to liver
cirrhosis and hepatocellular carcinoma, a leading cause of cancer-
related morbidity and mortality worldwide [1,2].
HBV is a small enveloped hepatotropic DNA virus which
replicates by reverse transcription of an RNA intermediate, the
pregenomic (pg) RNA (for review: [3,4]), to yield encapsidated,
partially double-stranded rcDNA to which the viral polymerase is
covalently bound [5]. Upon infection, rcDNA is transported to the
host cell nucleus where it is converted into cccDNA (Figure S1).
Episomal cccDNA then acts as template for all viral transcripts.
These include the subgenomic RNAs encoding the surface
proteins, and the pgRNA that serves as mRNA for the polymerase
protein and the capsid, or core, protein. Binding of polymerase to
the RNA stem-loop structure e initiates packaging of one pgRNA
molecule per newly forming capsid and its reverse transcription.
The first product is single-stranded (ss) DNA of minus polarity; due
to the unique protein-priming mechanism, its 59 end is, and
remains, covalently linked to the polymerase. The pgRNA is
concomitantly degraded, except for its 59 terminal ,15–18
nucleotides which serve as primer for plus-strand DNA synthesis,
resulting in rcDNA and, as a side-product, some double-stranded
linear (dl) DNA. DNA-containing capsids are then enveloped by
surface proteins and cellular lipids and secreted as virions.
Alternatively, they are redirected to the nucleus to increase
cccDNA copy number by a mechanism termed intracellular
recycling; many estimates for cccDNA copies per infected
hepatocyte are in the range of 5 to 50 [6]. This amplification
prevents loss during cell division of the cccDNA which can not be
replicated semiconservatively [7]. Thus, cccDNA formation and
recycling are central to establish and maintain persistent infection,
and they limit the efficacy of antiviral nucleot(s)ides in the
treatment of chronic hepatitis B, as these do not directly target
cccDNA (for review: [8]).
However, despite its central importance the molecular pathway
driving the conversion of HBV rcDNA to cccDNA is poorly
understood. In vivo studies face numerous challenges. Liver
biopsies from human patients are scarce, affected by the natural
history of infection, and they sample only a small volume of the
liver; recent estimates for cccDNA content in infected human liver
vary from 0.01 to 1.4 [9] to 0.1 to 10 copies per hepatocyte [10],
with large patient-to-patient variation. Kinetic studies during acute
infection, doable exclusively in chimpanzees, showed peak values
of around 10 cccDNA copies per infected cell but much lower
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settings, on the other hand, such as transfected cell lines [12–14] or
HBV-transgenic mice [15,16], HBV produces little if any
cccDNA.
DHBV is a related animal virus that is widely used as a model to
study HBV infection [17]. Like HBV, DHBV produces cccDNA
in cultured duck hepatocytes and in vivo [7,18], with reported
mean values of 2.9 to 8.6 copies per hepatocyte [19] though also
with temporal and cell-to-cell fluctuations (from one to .36 copies
per cell). Importantly, DHBV transfected into the chicken
hepatoma line LMH also generates well detectable amounts of
cccDNA. Initially in primary duck hepatocytes, then using that
system, Summers and colleagues had first shown that knocking out
surface protein expression, and thus virion secretion, dramatically
increased cccDNA copy numbers per nucleus to about 200–400
molecules [20,21]. Recent studies in stably or transiently
transfected human cell lines suggest that preventing HBV surface
protein expression also stimulates cccDNA formation, but to a
much lower degree; instead, a ‘‘protein-free’’ form of rcDNA (pf-
rcDNA) accumulated [12,13]. The term protein-free (which we
will adhere to here) was operationally defined by the partitioning
of this rcDNA form into the aqueous phase upon phenol
extraction without prior proteinase K (PK) treatment (which
artificially degrades the protein); polymerase-linked DNA parti-
tions into the organic phase. ‘‘Protein-free’’ does therefore not
imply the complete absence of any amino acid from the DNA.
Though not finally proven, several lines of indirect evidence
suggest that pf-rcDNA is a precursor to cccDNA [12,13]; not the
least, removal of the bound polymerase is a sine qua non for
cccDNA formation. Caveats are that nicked cccDNA, generated
to some extent during preparation and naturally protein-free, has
the same electrophoretic mobility as pf-rcDNA. Furthermore,
Southern blots from infected liver nuclei have generally shown
only little rcDNA versus cccDNA [22]. However, in such samples
one usually looks at an established pool of cccDNA whereas the
recent cell culture studies monitored initial cccDNA formation.
Potential precursors accumulating under these conditions may not
be detectable anymore in in vivo samples.
At any rate, the initial presence of protein-bound rcDNA inside
virions and eventually of nuclear cccDNA, associated with histones
[23], requires as intermediate steps nuclear transport of the
rcDNA genome, its release from the viral capsid and removal of
the bound polymerase to allow generation of precisely one genome
length equivalents of the plus- and the minus-strand before final
ligation into cccDNA (Figure S1B). The order of events is not
firmly established. Intact nucleocapsids may deliver the protein-
bound rcDNA to the nucleus where its release from the capsid and
polymerase removal are mediated by host factors; this view is
supported by the minimalistic genomes of hepadnaviruses (only
,3 kb) and by data from nuclear transport model systems [24,25].
Alternatively, the nucleocapsid itself may contain corresponding
activities such that polymerase removal could precede capsid
release, possibly already in the cytoplasm. Some evidence in favor
of this view has recently been forwarded [13,26].
Apart from these mechanistic aspects it appears, in essence, that
DHBV in the avian LMH cells produces much more cccDNA
than HBV in human hepatoma cells. One conceivable explanation
are cell-specific differences. For instance, the routinely used
human HepG2 and Huh7 hepatoma cell lines may lack enzymatic
activities required for cccDNA formation that are present in the
avian cells. Alternatively, the different efficiencies in cccDNA
formation may be a feature of the respective viruses.
In order to address this question we took advantage of the
principal ability of hepadnaviruses to replicate in hepatoma cell
lines of heterologous species origin. After transfection HBV is
capable of producing rcDNA in LMH cells and the same holds for
DHBV in HepG2 and HuH7 cells [27,28]. However, cccDNA
formation in such cross-species transfections has not yet been
addressed. Here we performed such experiments and found that,
unexpectedly, the major contribution to cccDNA formation comes
from the virus rather than from the cell.
Results
Intracellular recycling of HBV genomes occurs at very low
levels
Detection of cccDNA by Southern blotting can severely be
hampered by the presence of ssDNA species which have a similar
electrophoretic mobility and are often present in excess. A further
problem in transient transfections is the highly abundant plasmid
DNA. We therefore developed an assay that essentially eliminates
ssDNA and plasmid DNA by double-digestion with the restriction
enzyme Dpn I and Plasmid safe DNase (PsD). Dpn I requires
bacterially methylated DNA to be active and selectively restricts
the transfected plasmid. PsD digests single-stranded (ss) and
double-stranded linear (dl) but not circular molecules such as
cccDNA. Although it has been surmised that rcDNA is a substrate
for PsD [9], our own preliminary data suggested this holds only for
very immature rcDNA forms. To enhance cccDNA production,
we used plasmids coding for surface-deficient HBV and DHBV.
Because cccDNA is enriched in the nucleus, we separated nuclei
from cytoplasm by treating the cells with the mild detergent NP-40
and subsequent centrifugation. To identify encapsidated DNAs,
we incubated the cytoplasmic extracts with micrococcal nuclease
(MN) which digests free nucleic acids but not those protected
inside capsids. Finally, because protein-bound DNA is neither
recovered upon phenol extraction nor using the silica column
adsorption (QIAamp) method employed here, all initial DNA
preparations included a PK treatment.
Author Summary
Persistent infection with hepatitis B virus (HBV) causes
chronic hepatitis B which frequently progresses to
hepatocellular carcinoma, a leading cause of cancer-
mediated mortality worldwide. Persistence requires forma-
tion and amplification of covalently closed circular
(ccc)DNA, an episomal form of the viral genome that is
not targeted by current drugs and thus is responsible for
the notorious difficulties in therapeutic elimination of
infection. Initial generation of cccDNA occurs upon nuclear
import of the virion-borne relaxed circular (rc) DNA to
which the viral polymerase is covalently linked; amplifica-
tion occurs via intracellular recycling. The underlying
molecular pathway is poorly understood. Because HBV
infects only primates, in vivo studies are extremely
restricted; in vitro, select hepatoma cell lines transfected
with HBV support viral replication, however with little if
any cccDNA formation. Here, we compared intracellular
recycling of HBV and DHBV, a model hepatitis B virus from
ducks, in cross-species transfections. Surprisingly, the
major contribution to cccDNA formation comes from the
virus rather than the cell as DHBV but not HBV rcDNA
converted efficiently into cccDNA in the same human cell
background. This unexpected difference might help to
better understand persistence of HBV infection; efficient
DHBV cccDNA formation in human cells provides a new
tool to facilitate identification, and possibly targeting, of
the human cell factors involved.
Intracellular Recycling of HBV Genomes
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shown in Figure 1. Treatment of the cytoplasmic samples with MN
revealed the common replicative intermediates, i.e. rcDNA,
dlDNA and ssDNA. Digestion with Dpn I only produced a
similar pattern, except that additional plasmid-derived bands (Pla)
were visible. Nuclear DNA treated with Dpn I alone produced a
similar pattern, yet as expected, knock-out of surface protein
expression enhanced the cccDNA signal, particularly for DHBV.
Additional treatment of nuclear DNA with PsD removed all bands
except those at the rcDNA and cccDNA positions; the equal signal
intensities before and after PsD treatment demonstrated that
mature rcDNA was not appreciably attacked by PsD. For HBV, a
band at the cccDNA position was exclusively visible in the surface-
deficient background (Figure 1B). However, the nuclear rcDNA
signal was much more enhanced, in line with recent reports
[12,13]. Comparable results were obtained in Huh7 cells (Figure
S2A). Together, these data demonstrated that the applied
procedure enabled the reliable detection of cccDNA and rcDNA,
without interference from other virus- or plasmid-derived nucleic
acids. Furthermore, they confirmed that DHBV in avian cells
produces much more cccDNA than HBV in human cells.
Faint bands with cccDNA-like mobility were also detectable in
the cytoplasmic fractions of those samples containing well visible
nuclear cccDNA; ethidium bromide staining of the agarose gel
used to generate the blot revealed indeed some chromosomal
DNA in the cytoplasmic samples, indicating an incomplete
separation of two fractions. This prompted us to employ a more
efficient separation procedure in later experiments (see below).
The virus, not the cell, is the major determinant for
efficient cccDNA formation
Next we performed analogous experiments with DHBV
transfected into the human cell lines, and HBV transfected into
LMH cells (Figure 2). For DHBV, cytoplasmic extracts treated
with MN produced a similar pattern of replicative intermediates in
HepG2 (Figure 2A) and HuH7 cells (Figure S2B) as in LMH cells
(Figure 1A). HBV in LMH cells, compared to the human cell lines,
generated a more complex pattern with a distinct band of an
intermediate mobility between rcDNA and ssDNA (Figure 2B).
This additional band originates from strongly enhanced splicing of
the HBV pgRNA in the chicken cell line (Ko ¨ck, Nassal, Thoma;
unpublished data). The spliced genomes are of linear conforma-
tion and therefore accessible to PsD digestion. Most importantly
for the current study, the envelope-deficient DHBV produced a
strong cccDNA signal in both human cell lines (Figure 2A and
Figure S2B), with an intensity equaling that of the nuclear rcDNA
as in LMH cells. Conversely, HBV in LMH cells generated a
similar pattern as in the human cell lines, with a relatively strong
band at the rcDNA yet only a weak band at the cccDNA position
(Figure 2B). The HBV specific lack of effect of the envelope knock-
out in LMH cells correlated with a much lower abundance of the
surface protein-coding mRNAs compared to the human cells (data
not shown). Thus wild-type HBV in LMH cells is phenotypically
similar to its envelope-deficient counterpart.
Together, these data demonstrated that both HepG2 and
HuH7 cells are competent to support cccDNA synthesis, yet with
strikingly higher efficiency for DHBV than HBV; conversely,
LMH cells did not support more efficient cccDNA formation for
HBV. These results were reproduced in about twenty independent
experiments. Furthermore, this virus-specific difference was
neither changed by increasing pgRNA levels via replacement of
the HBV core promoter by the CMV promoter, nor by analyzing
the cultures at earlier or later time points post transfection (Figure
S3). Thus the virus contributes more profoundly to the efficiency
of cccDNA biosynthesis than the cell. More quantitative data on
the amounts and intracellular distribution of the different viral
DNA were obtained with samples from gradient purified nuclei.
Purification of cell nuclei by sucrose gradient
sedimentation
Beyond the markedly different levels of cccDNA, the data
shown above also revealed distinct levels of nuclear rcDNA, and of
the ratios of cccDNA to rcDNA, between DHBV and HBV. A
detailed characterization of the nuclear rcDNA was expected to
provide clues on the rate-limiting step of HBV cccDNA synthesis.
This, however, required the nuclear preparations to be as free
from cytoplasmic contamination as possible. We therefore
separated the nuclei from the cytoplasm by sucrose density
sedimentation [29]. Western blot analyses of nuclear extracts
versus total cell lysates showed that, while nuclear histone H3 was
detected in either fraction, the cytoplasmic poly(A) binding protein
(PABP) was exclusively present in total cell lysates but not in
Figure 1. DHBV replication in avian cells and HBV replication in
human cells. (A) Chicken LMH cells transfected with wild-type and
surface-deficient DHBV. (B) Human HepG2 cells transfected with wild-
type and surface-deficient HBV. DNAs were extracted, after prior PK
digestion, from cytoplasmic lysates and the nuclear fractions. One
aliquot of the cytoplasmic lysates was treated with micrococcal
nuclease (MN) before DNA extraction and analyzed without further
treatment. All other samples were incubated, post extraction, with
either Dpn I alone (Dpn), or Dpn I plus Plasmid safe DNAse (Dpn+PsD).
Nomenclature of the various DNA species: RC, relaxed circular; DL,
double strand linear; SS, single strand; CCC, covalently closed circular
DNA; Pla, Dpn I restriction fragments of transfected plasmid DNA.
doi:10.1371/journal.ppat.1001082.g001
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capsids with the nuclei was ruled out by the absence of viral DNAs
from purified nuclei of non-transfected HepG2 cells that had been
mixed with capsid-containing cytoplasmic fractions from HBV- or
DHBV-transfected cells and subjected to the same procedure
(Figure S4B). Permeability of the nuclei for exogenously added
MN, an assay subsequently used to address nuclease sensitivity vs.
resistance of the nuclear viral DNAs, was confirmed by dose-
dependent generation of chromosomal DNA fragments with sizes
of multiples of ,150 bp, as expected from cleavage between
nucleosomes (Figure S4C).
Less efficient nuclear transport of HBV versus DHBV
rcDNA may contribute to but does not solely explain less
efficient cccDNA accumulation
Applying this methodology to HepG2 cells transfected with
surface-deficient HBV or DHBV constructs revealed that the
purified nuclei contained easily detectable signals at the rcDNA
position, and for DHBV a strong and for HBV a weak signal at the
cccDNA position; as expected, both converged into a single species
with dlDNA mobility upon digestion with Eco RI, and heating
converted the rcDNA but not the cccDNA signal into a new band
with ssDNA mobility (Figure S5A). However, this assay does not
discriminate true rcDNA from randomly nicked cccDNA. For
distinction, we exploited the defined discontinuities at the 59 ends
of the complete minus-strand and the 39 terminally incomplete
plus-strand DNA (Figure 3A) in rcDNA and the requirement of
most restriction enzymes for a double-stranded substrate structure.
The nuclear, and for comparison also the cytoplasmic, HBV DNA
preparations were incubated with Nco I whose recognition site
(CCATGG; nt positions 2654–2659) is in the 39 proximal part of
the plus-strand but largely double-stranded already in virion DNA
(e.g. [30]); Fsp I (TGCGCA; nt positions 3082–3087), recognizing
a site in the 59 proximal plus-strand region that is double-stranded
even in DNA with very short plus-strands; and Apa LI (nt positions
2861–2866), with its recognition site (GTGCAC) ending only 5 nt
upstream of DR2 (nt positions 2872–2882) where the plus-strand
begins. Nicked cccDNA should be linearized by all three enzymes
whereas true rcDNA, depending on how far the plus-strand is
Figure 2. DHBV replication in human cells and HBV replication
in avian cells. (A) DHBV in HepG2 cells. (B) HBV in LMH cells. Labeling
and abbreviations are as in the legend to Figure 1. The position of a
major DNA product of about 2 kb in length derived from enhanced HBV
splicing in LMH cells is indicated (spl).
doi:10.1371/journal.ppat.1001082.g002
Figure 3. Site-specific discontinuity confirms the rcDNA nature
of a substantial fraction of nuclear HBV DNA. Extensive nicking of
HBV cccDNA might pretend an artifactually high ratio of rcDNA to
cccDNA in the nucleus. However, nicking should occur at random
whereas RC-DNA is distinctly discontinuous where the minus-strand
and plus-strand DNA start. (A) Scheme of HBV rcDNA discontinuities.
Restriction site positions are indicated with the first and last nucleotide
of the recognition sequences. The Apa LI site is located immediately
upstream of the plus-strand start. DNA in which the plus-strand is not
sufficiently extended can not be cut. DR1 and DR2, direct repeats 1 and
2; wavy line at DR2, RNA primer at plus-strand 59 end. (B) About one
third of the rcDNA signal is resistant to Apa LI but not Nco I or Fsp I
digestion. Cytoplasmic (treated with MN) and nuclear (treated with Dpn
I) DNA preparations (both after prior PK digestion) were incubated with
the indicated restriction enzymes. Consistently (Figure S5B), ,35% of
the rcDNA signal from the cytoplasm as well as the nucleus remained
upon incubation with Apa LI (arrowheads) but not Nco I or Fsp I.
Activity of Apa LI in the reactions is documented by the absence of a
plasmid-derived Dpn I fragment containing internal sites for Apa LI and
Fsp I but not Nco I. All samples were run on the same gel but a six-times
longer exposure is shown for the nuclear samples; lane 5L on the longer
exposure corresponds to lane 5 on the left panel. M, marker fragments
of the indicated sizes (in kb).
doi:10.1371/journal.ppat.1001082.g003
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LI cleavage. Exactly this was observed, with about 35% of the
rcDNA remaining in the Apa LI but not the Nco I and Fsp I
treated samples from both the cytoplasm and the nucleus; very
similar results were obtained in repeat experiments (42.2610.7%
for the nuclear and 40.062% for the cytoplasmic rcDNA), as well
as for protein-free nuclear rcDNA (32.064.9%; Figure S5B). The
differences between different treatments were highly significant
(P,0.05 to ,0.001) but those between cytoplasmic vs. nuclear
rcDNA were not. Activity of Apa LI in the reactions was
demonstrated by the disappearance of the Dpn I fragment from
the transfected plasmid DNA that harbors the single virus genome-
encoded recognition sites for Apa LI and Fsp I but not Nco I.
Furthermore, an admixed DHBV plasmid was completely cut by
either enzyme (Figure S5B). Hence, in accord with previous
reports [12,13], a substantial fraction of the nuclear HBV rcDNA
signal was derived from true rcDNA, confirming that the weak
cccDNA signal was not caused by excessive nicking.
For a quantitative estimate of the proportion of nuclear versus
cytoplasmic HBV and DHBV rcDNA, we compared the amounts of
viral DNA in total cells (nuclei plus cytoplasm) and in gradient-
purified nuclei; to account for all DNA species regardless of
encapsidation and protein-linkage status, preparations involved PK
treatment and subsequent digestion with Dpn I plus PsD, but not
MN. Serial dilutions served to improve the accuracy of quantitation
by phosphorimaging; one of three independent experiments used for
quantitation is shown in Figure 4A. The signals from the four
different amounts of total rcDNA (1%, 3%, 10%, and 30% of the
whole preparation) and from the 30% portions of nuclear rcDNA
were quantitated and corrected for background byphosphorimaging.
Accordingly, the ratios for total vs. nuclear rcDNA were 3.660.44 : 1
for DHBV, and 6.860.26 : 1 for HBV, i.e. about 25–30% of the
DHBV and around 15% of the HBV rcDNA were nuclear.
Using the known amounts of HBV and DHBV marker DNAs
run on the same gels we also estimated the amounts per sample
(one well of a 6-well plate) of total versus nuclear rcDNA and
cccDNA, and the copy numbers per transfected cell (see Text S1
for details); accordingly, DHBV generated ,160 pg (161.6628.3;
200635 copies) total rcDNA of which ,45 pg (44.864.5; 5666
copies) were nuclear, and HBV produced ,130 pg (130.267.6;
162610 copies) total rcDNA of which ,20 pg (19.261.1; 2562
copies) were nuclear. Amounts of cccDNA estimated analogously
were ,45 pg (42.363.3; 5665 copies) for DHBV, and ,2p g
(2.160.9; 2.661.1 copies) for HBV; cccDNA values for HBV were
close to background and therefore difficult to determine more
accurately. However, a similar excess of nuclear HBV rcDNA over
cccDNA has also been reported for inducible cell lines stably
transfected with surface-deficient HBV [12,13]. Together these
data indicated that less efficient nuclear transport of HBV rcDNA
contributes to, but cannot solely be responsible for, the much less
efficient cccDNA accumulation.
Nuclear HBV but not DHBV full-length rcDNA is highly
accessible to exogenously added nuclease
To further investigate the status of the viral DNAs, we treated
total lysates and purified nuclei with MN followed by PK, leaving
only encapsidated (or otherwise protected) DNA species intact. For
DHBV, the results were essentially the same (Figure S6, panel
DHBV) as those after Dpn I plus PsD treatment (Figure 4A) but for
HBV the signal at the full-length rcDNA position had nearly
disappeared, apparently in favor of faster migrating species (Figure
S6,panelHBV).Fora directestimateofthefractionofMNsensitive
nuclear DNA species, viral DNA was isolated from equally sized
aliquots of the nuclei by either the Dpn I plus PsD or the MN
procedure and analyzed side-by-side (Figure 4B). For DHBV the
total amounts of rcDNA obtained in either way were very similar,
indicating that most of the nuclear DHBV DNA was present in
largely intact nucleocapsids (as confirmed by anti-capsid immuno-
precipitation; see below). The nonetheless strong cccDNA signal
suggested that once released from the capsid, DHBV rcDNA gets
rapidly converted into cccDNA; alternatively, the stably encapsi-
dated nuclear DHBV rcDNA might be a dead-end product.
For HBV, in contrast, only the cytoplasmic rcDNA signal was
largely resistant to MN whereas in the nuclear sample faster
migrating species accumulated (Figure 4B and Figure S6);
quantitative comparison of the nuclear full-length rcDNA signals
with versus without MN treatment from three independent
transfections showed that only about 10% (11.166.3%) of the
full-length rcDNA was resistant. Hence different from DHBV,
most of the nuclear HBV rcDNA was sensitive to MN and
therefore no more protected by an intact capsid shell.
Core protein association of nuclease sensitive nuclear
HBV rcDNA indicates partial disintegration of the HBV
capsid in the nucleus
The nuclease sensitivity of most of the nuclear HBV full-length
rcDNA was compatible with its complete release from the capsid;
Figure 4. Intracellular distribution and nuclease sensitivity of
viral DNAs. HepG2 cells were transfected with vectors for surface-
deficient DHBV (left panels) or HBV (right panels). (A) Relative nuclear
distribution. DNA was extracted, after prior PK treatment, from total
cells or from gradient-purified nuclei and subsequently digested with
DpnI plus PsD. Serially diluted samples were loaded on the gel. Loading
volumes are indicated in percent of the total sample volume, obtained
from one well of a 6-well plate. One of three experiments used for
quantification (see text for details) is shown. (B) Direct comparison of
MN resistant versus total nuclear viral DNA. DNA was prepared from
total cell extract treated with MN plus PK (MN), or from gradient-
purified nuclei; equal aliquots of the nuclei were treated with MN plus
PK before DNA extraction (MN), or with only PK followed by incubation
with Dpn I plus PsD (total nuclear DNA). A six times longer exposure for
the nuclear HBV samples is shown to better reveal weak signals.
Quantification indicated that only ,10% of the nuclear full-length HBV
versus $80% of the nuclear DHBV DNA were MN resistant.
doi:10.1371/journal.ppat.1001082.g004
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shorter DNAs that were still fully encapsidated. Alternatively,
partial opening of the capsid could have exposed parts of, but not
the entire full-length DNA to nuclease attack; finally, partial
protection could also have arisen from association with factors
other than core protein.
We therefore assessed whether the nuclear viral DNAs could be
immunoprecipitated by antibodies against the respective core
proteins. Purely osmotic procedures released much less core
protein from the gradient-purified nuclei than lysis with 0.5% SDS
which, however, disintegrates capsids and prevents analysis of
capsid-associated nucleic acids. Instead we treated the nuclei with
0.756radioimmunoprecipitation (RIPA) buffer which destroys the
nuclear envelope but leaves the viral nucleocapsids intact [31].
The cytoplasmic lysates serving as reference source for the
immunoprecipitations (IPs) were likewise adjusted to 0.756RIPA.
As a specificity control, HBV samples were incubated with anti-
DHBV core antibody and vice versa (mock-IP). Next, DNAs
associated with the immunopellets were isolated after prior PK
treatment and analyzed by Southern blotting.
For DHBV (Figure 5A), the immunoprecipitated DNA from
both the cytoplasm and the nuclei, if treated with only Dpn I,
generated a similar pattern as that obtained by direct incubation of
the extracts with MN (lanes ø), except it contained some
fragmented plasmid DNA; this was found in similar amounts in
the mock-IP and represented at most 50 pg, i.e. a tiny fraction of
the transfected plasmid DNA. MN treatment of the immunopellets
completely removed the residual plasmid DNA, as well as a faint
band at the cccDNA position seen only in the nuclear
immmunopellets, but left most of the viral rcDNA and dlDNA
intact. Hence the non-ccc forms of DHBV DNA in the cytoplasm
and nucleus behaved alike: both were immunoprecipitable with
anti-DHBV core antibody and both were largely protected from
nuclease, consistent with their being stably encapsidated in either
compartment.
For HBV (Figure 5B), the picture in the cytoplasmic samples
was similar; the anti-HBV core antibody precipitated the same
type of DNAs as obtained by direct MN treatment; residual
plasmid DNA was completely removed by MN. The nuclear
immunopellet, if treated with Dpn I only, generated a similar
pattern as that from the cytoplasm; hence at least part of the
nuclear full-length rcDNA was still core protein-associated.
However, like direct incubation of the nuclei with MN
(Figure 4B), MN treatment strongly reduced the full-length
rcDNA signal whereas faster migrating DNA species accumulated,
suggesting their resistance was indeed due to protection by the
capsid. Comparable results were obtained in Huh7 (Figure 5B, left
panel) and in HepG2 cells (Figure 5B, right panel; cytoplasmic
samples of this experiment are shown in Figure S7). Together
these data indicated that at least a fraction of the nuclear HBV
DNA including full-length species was still associated with core
protein but, different from DHBV, was no more fully protected.
Restriction of partially nuclease-resistant nuclear HBV
DNA suggests region-selectively opened nucleocapsids
as a putative uncoating intermediate
The majority of MN resistant nuclear HBV DNAs migrated
reproducibly to a region whose upper boundary would correspond
to dlDNA of ,2.4–2.7 kb (Figure 4B). One explanation was that
these molecules represented naturally shorter DNA derived from
spliced pgRNA [32,33] which remained protected in intact
nucleocapsids. However, a construct encoding a variant HBV
genome in which the major splice acceptor site was mutated
generated exactly the same pattern of MN resistant nuclear DNA
although splicing was indeed suppressed (data not shown). Next we
incubated the MN resistant nuclear, and for comparison also
cytoplasmic, HBV DNA with restriction enzymes Nco I and Spe I
which cut the HBV genome uniquely at positions 2654 and 1961
(Figure 6A, C). Expectedly, the major effect on the cytoplasmic
DNA was conversion of the rcDNA to dlDNA, plus generation of
small amounts of fragments that most likely derived from dlDNA;
ssDNA was not affected. In the nuclear sample, the little full-length
rcDNA was linearized as well. The major faster migrating species
disappeared completely upon exposure to either enzyme, indicat-
ing they contained both recognition sites in double-stranded form.
Intriguingly, within the background smear distinct fragments of
about 2.2 kb (Nco I) and 1.2 kb (Spe I) appeared that were absent
from the non-restricted sample, suggesting that MN had generated
at least one relatively distinct new DNA end at a fixed distance
from the restriction sites. One interpretation was that the MN
products of rcDNA lacked about 500 bp roughly between position
3000 and 500 (see map in Figure 6C); in that case the second Nco
I fragment would comprise only around 300 to 400 bp which,
together with some heterogeneity in size, would make it difficult to
Figure 5. Core protein association of nuclear DHBV and HBV
DNA. Vectors for surface-deficient DHBV and HBV genomes were
transfected into Huh7 cells. IPs were performed in cytoplasmic extracts
and extracts of purified nuclei containing 0.756 RIPA buffer, using
antibodies against DHBV core protein (aDc) or HBV core protein (aHBc);
in the mock IPs aDc was replaced by aHBc and vice versa.
Immunopellets were treated with MN or not as indicated, and extracted
after prior PK digestion. Purified DNAs from not MN-treated samples
were digested with Dpn I. ø, extract directly treated with MN. (A) DHBV.
M1, marker for cccDNA and rcDNA; M2, marker for single-stranded DNA;
* and **, positions of cccDNA and ssDNA, respectively. (B) HBV. The
rightmost panel shows the nuclear samples from an analogous
experiment in HepG2 cells; the cytoplasmic samples are shown in
Figure S7.
doi:10.1371/journal.ppat.1001082.g005
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could consist of two about equally sized products. To corroborate
this assumption, we digested the nuclear MN resistant DNAs with
three more single cutter enzymes (Figure 6B): Nsi I and Eco RI
(recognition sites starting at positions 2346 and 1280, respectively),
and Bsp EI (recognition site starting at position 429 in the
predicted lacking sequence part). As a further control, intact
nuclear rcDNA was isolated by the Dpn I plus PsD procedure and
digested with the same enzymes which in all cases led to complete
linearization (Figure 6B, left panel). In the MN treated nuclear
DNA, the rcDNA signal likewise disappeared completely in favor
of a new band at the dlDNA position. Importantly, however, Nsi I
and Eco RI produced distinct new bands of about 1.9 kb (marked
by *), whereas for Bsp EI the pattern below the dlDNA position
was not detectably different from that of the untreated sample
(lanes ø). These data are consistent with MN generating from
nuclear HBV rcDNA a relatively distinct mixture of double-
stranded linear DNAs that lack approximately the region between
position 3000 and 500 (Figure 6C). This, in turn, implies that
capsid opening occurs at distinct sites relative to the packaged
genome.
Together, these data indicated that nuclear HBV genome
release from the capsid is efficiently initiated; at most 10% of the
full-length rcDNA remained resistant to MN. Furthermore, as
shown below, we also found evidence for a fraction of nuclear
rcDNA that is completely released from the core protein. Hence
poor HBV rcDNA to cccDNA conversion is not caused by a
complete block of uncoating dynamics.
The majority of nuclear HBV full-length rcDNA is not
linked to viral polymerase protein
To test the polymerase linkage status of the different viral DNAs
we prepared cytoplasmic extracts and purified nuclei from DHBV
and HBV transfected HepG2 cells. Equal aliquots from each
sample were then incubated in buffer containing SDS with or
without PK, and subjected to conventional phenol extraction.
Transfected plasmid DNAs were digested with Dpn I (Figure 7A).
Without PK, only very weak signals were seen for both HBV and
DHBV in the cytoplasmic fractions (,10% of the signals with PK),
in line with a previous report [12] though not with an other [13];
evaluation of 15 independent HBV samples gave a mean value of
9.262.4%.
In the nuclei of the DHBV transfected cells, PK treatment had,
expectedly, little effect on cccDNA and the plasmid derived Dpn I
fragments (Figure 7A, left panel); but strongly enhanced the
rcDNA signal. For nuclear HBV rcDNA, in contrast, the signals
obtained without PK were nearly as strong as those from the PK
treated aliquot (Figure 7A, right panel). For a semiquantitative
estimate we compared the rcDNA signal intensities with versus
without PK treatment from two independent experiments; to
account for differencies in recovery, these values were normalized
for the cccDNA signals (DHBV) and the plasmid fragments
(HBV), respectively, in the same lanes. Accordingly, the rcDNA
signals from the PK treated samples were 3.7860.54 fold stronger
for DHBV, and 1.1760.29 fold stronger for HBV, indicating that
around 20% of the nuclear DHBV rcDNA and around 70% or
more of the nuclear HBV rcDNA were protein-free. Comparing
11 different pairs of PK treated vs. non-treated nuclear HBV
samples yielded a mean value of 66.9613.3% protein-free rcDNA.
That a major fraction of the rcDNA signals originated from true
rcDNA was corroborated by subjecting nuclear HBV DNA
obtained with or without prior PK treatment to digestion with Nco
I, Apa LI, and FspI. As before (Figure 3), Nco I and Fsp I
converted the PK treated rcDNA nearly completely into dlDNA,
whereas about 40% of the rcDNA signal remained upon Apa LI
digestion (Figure S5B); for the protein-free nuclear DNA the mean
value was slightly lower (3265%), suggesting it contained more
completely filled-in plus-strand DNA. However, this difference
was not statistically significant.
We also assessed the polymerase linkage status of the MN
resistant DNAs (Figure 7B). The patterns generated upon prior PK
treatment fully matched those previously seen (Figure 4B, C, S6)
whereas without PK treatment only faint signals were detectable.
For DHBV, the nuclear and cytoplasmic DHBV DNAs were
similar in composition and both were largely polymerase-linked.
With, but not without PK treatment, nuclear HBV DNA showed
Figure 6. Restriction mapping of nuclear HBV rcDNA suggests genome region-selective MN accessibility. (A) Cytoplasmic versus
nuclear MN-resistant viral DNAs. DNAs were isolated from HepG2 cells transfected with the surface-deficient HBV vector after prior MN plus PK
treatment, and incubated with restriction enzymes Spe I and Nco I (ø, no restriction). Amounts equivalent to 10% of the total cytoplasmic fraction and
90% of the total nuclear fraction were loaded. (B) Total nuclear rcDNA versus MN resistant nuclear DNA. Viral DNA from isolated nuclei was prepared
by either the PK plus Dpn I plus PsD procedure (total nuclear rcDNA), or after prior MN plus PK treatment (MN resistant nuclear DNA), and incubated
with Nsi I, Eco RI or Bsp EI. Asterisks denote newly formed distinct fragments; lane ø on the right is a longer exposure of lane ø on the left. (C)
Restriction map of HBV. The restriction sites probed in A and B are indicated. DR1 and DR2, direct repeats 1 and 2; P, covalently linked polymerase;
wiggly red line, RNA primer at (+)-DNA 59 end. Together, the patterns can consistently be explained if MN treatment removed a defined region from
the rcDNA that approximately encompasses position 3000 to 500.
doi:10.1371/journal.ppat.1001082.g006
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(Figure 4B). Hence the MN resistant shorter HBV DNA species as
well as the small amounts of resistant full-length rcDNA were
mostly protein-linked. This suggested that the relatively high
proportion of protein-free species in the total nuclear DNA
(Figure 7A) was largely accounted for by MN sensitive rcDNA
molecules.
Evidence for a fraction of nuclear HBV full-length rcDNA
that is completely released from the capsid
The IP experiments described above (Figure 5B) indicated an
association of at least some of the nuclear HBV full-length rcDNA
with core protein. Hence failure to completely uncoat the DNA
could represent a rate-limiting step in cccDNA formation. We
therefore assessed whether the nuclei also contained rcDNA
molecules that were no more associated with core protein. To this
end, we performed IPs as before yet this time we included the IP
supernatants in the analysis. Furthermore, we addressed the
polymerase linkage status of such putative species by treating one
half of each sample with PK, the other not. Cytoplasmic samples
in which the viral DNA is largely present in intact capsids (Figure 5)
served as control. Because MN would destroy nonprotected
rcDNA, we used Dpn I plus PsD to reduce the background of non-
rcDNAs.
The specific IP from the cytoplasm generated a strong rcDNA
signal in the immunopellet after PK treatment; the signal from the
supernatant was only 3–4% as intense (Figure 8, lane 2 vs. 4).
Conversely, the signal from the mock IP pellet had less than 3%
the intensity of that from the supernatant (lane 6 vs. 8). These data
confirmed that the IP was specific and that the amount of anti-
HBc antibody was sufficient to precipitate $95% of the
cytoplasmic rcDNA. The strongly reduced signals without PK
treatment further corroborated that 90% or more of the
cytoplasmic rcDNA was protein-linked.
A different picture was seen in the nuclear samples. The anti-
HBc supernatant contained more rcDNA than the immunopellet
(lane 11 vs. 13); quantification indicated that only about 30% of
the rcDNA was precipitated (29.863.5% for the PK treated,
34.263.2% for the not treated sample; from duplicate determi-
nations of two independent experiments). For the mock IP, only
5.063.9% were found in the pellet (lane 15 vs. 17). In further
contrast to the cytoplasmic samples, yet in line with the previous
data (Figure 7A), omitting the PK treatment only modestly
reduced the signal intensities in all nuclear samples (lanes 11 vs.
12; 13 vs. 14; 17 vs. 18), i.e. to 73616% in the specific
immunopellet, to 6969% in the supernatant, and to 5567% in
the mock IP supernatant. Although the low overall signal
intensities precluded a more accurate determination, these data
indicated that around two thirds of the nuclear HBV rcDNA were
not stably associated with core protein, i.e. probably completely
uncoated, and around two thirds of these molecules were no more
linked to intact polymerase protein.
Completion of plus-strand DNA in serum-derived HB and
DHB virions is not sufficient for capsid release or
polymerase protein removal from rcDNA
The data described above were compatible with at least partial
release of the nuclear HBV rcDNA from the capsid, allowing cell
factors to engage in polymerase removal. A recently proposed
alternative is that polymerase removal might precede capsid
opening, possibly already in the cytoplasm and mediated by
capsid-intrinsic activities [26]. One line of evidence in favor of this
proposal was the reported generation of small amounts of protein-
Figure 7. Polymerase linkage status of cytoplasmic versus
nuclear viral DNAs. HepG2 cells were transfected with vectors for
surface-deficient DHBV (left panels) or HBV (right panels). (A) Full-length
rcDNA. DNA was extracted from cytoplasmic lysate (cyto) or gradient-
purified cell nuclei (nuc) by phenol extraction with or without prior PK
treatment (+/2 PK) and subsequently incubated with Dpn I. For HBV
small amounts of partial Dpn I digestion products extended up to close
to the position of ssDNA (Pla). Note the comparably strong signal for
nuclear, but not cytoplasmic, HBV rcDNA even without PK treatment.
(B) Nuclease resistant DNAs. Cytoplasmic lysate and gradient-purified
nuclei were treated with MN. Subsequently, DNA was prepared by
phenol extraction with or without prior PK digestion. All samples not
treated with PK produced only weak if at all detectable signals.
doi:10.1371/journal.ppat.1001082.g007
Figure 8. Evidence for a fraction of completely uncoated,
largely protein-free nuclear HBV RC-DNA. HepG2 cells were
transfected with the vector for surface-deficient HBV. IPs were
performed as in Figure 5, except that DNA from both the immunopel-
lets (pel) and the supernatants (sup) was analyzed; in addition, the
samples were treated, or not treated, with PK prior to DNA extraction as
indicated. Note the high proportion of rcDNA in the aHBc supernatant
from the nuclear vs. cytoplasmic sample, and the likewise high
proportion of rcDNA signals in the nuclear vs. cytoplasmic samples
not treated with PK.
doi:10.1371/journal.ppat.1001082.g008
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prolonged endogenous polymerase reaction (EPR) conditions; no
results for HB virions were reported. In the EPR, exogenously
added dNTPs are utilized by the capsid-borne (‘‘endogenous’’)
polymerase to complete the plus-strand DNA. Because serum
virions are secreted from infected hepatocytes, there is very little
risk of cross-contamination with nuclear or other cellular factors.
Here we performed analogous experiments with HB virions,
and for comparison with the published results [26] also with DHB
virions. Nucleocapsids of either virus were obtained from highly
viremic sera by sedimentation in Nycodenz gradients containing
NP-40 detergent. DHBV nucleocapsids were exposed to EPR
conditions for 16 h [26], and the capsid-borne DNAs were isolated
via phenol extraction with or without prior PK treatment. The
corresponding Southern blot showed ample rcDNA and some
dlDNA in the PK treated but not the untreated sample (Figure 9A,
left panel), confirming that most of the virion-borne genomes are
covalently linked to polymerase. In line with the reported data, a
long exposure plus contrast enhancement (Figure 9A, right panel)
revealed indeed a faint band of apparently protein-free DNA,
however exclusively at the dlDNA, not the rcDNA position. By
comparison with the dilution series of the PK treated sample, the
protein-free dlDNA accounted for less than 0.3% of the total
capsid-borne virus DNA.
Analysis of the HB virion-derived nucleocapsids after PK
treatment but prior to the EPR (Figure 9B) showed a smear of
bands that migrated faster than mature rcDNA from transfected
HepG2 cells, indicating a relatively large gap in the HB virion
plus-strand DNA; no signal was visible without PK treatment
(Figure 9B). When subjected to EPR (Figure 9C, lanes +dNTP)
under the same conditions as used for DHBV, these species were
efficiently converted into rcDNA plus some dlDNA, confirming
enzymatic activity of the capsid-borne polymerase. The signal was
largely stable towards MN, indicating the vast majority of viral
genomes remained protected by the capsid shell. Without PK
treatment, no signal was visible, not even upon overexposure
(Figure 9C, right panel). Thus if plus-strand completion per se
caused any release from the capsid or removal of polymerase from
viral DNA, its extent for HBV was even less pronounced than for
DHBV. That, in contrast, in the nuclei of the transfected cells most
of the HBV rcDNA was sensitive to MN and protein-free (Figure 4,
5) strongly supports that HBV capsid opening and deproteiniza-
tion of rcDNA depend largely on the nuclear environment.
Discussion
Formation and amplification of cccDNA is essential for the
establishment and maintenance of HBV infection. The underlying
molecular pathway is poorly understood, not the least because
HBV in transfected human hepatoma cell lines, despite efficient
replication, produces very little cccDNA even if surface protein
expression is prevented. Unexpectedly, our cross species transfec-
tion experiments revealed that the very same cell lines support
efficient conversion of DHBV rcDNA into cccDNA. Our
characterization of the intranuclearly accumulating rcDNA species
showed that initiation of nuclear uncoating of the HBV rcDNA
was highly efficient whereas complete release from the capsid and
complete removal of the covalently linked polymerase contribute
to limiting cccDNA formation. However, ,40% of the nuclear
rcDNA were apparently fully capsid-released and polymerase-free,
hence a major block lies in the actual rcDNA to cccDNA
conversion process; for DHBV, such a block does not appear to
exist (Figure 10).
Validity of data
The conclusion of efficient DHBV but poor HBV rcDNA to
cccDNA conversion is based on the relative intensities of
Southern blot signals at the rcDNA and cccDNA positions in
nuclear preparations; a ratio of about 1:1 for DHBV but 10–20:1
for HBV was observed in more than 20 independent prepara-
tions. The selective partial resistance against Apa LI digestion of
nuclear HBV rcDNA (Figure 3, Figure S5) strongly suggests that
excessive nicking of HBV (but not DHBV) cccDNA is not a
major cause for the strong rcDNA versus weak cccDNA signals,
consistent with data from stably transfected cells [12,13]. Another
explanation would be that cccDNA of HBV has a much shorter
half-life than that of DHBV. The in vivo half-life of cccDNA may
be in the order of weeks to months [11,34,35] but the rates of
synthesis versus degradation are subject to numerous factors,
including cell division and immune responses. Closest to our
setting are values derived from inducible cell lines in which
rcDNA resynthesis was blocked by nucleoside analogs, with
estimates of .48 h for DHBV [36] and .10 to 24 d for HBV
[37]. Both values are long compared to the time frame of our
experiments and, if anything, HBV cccDNA seems to be more
stable than DHBV cccDNA. Hence it appears justified to assume
Figure 9. Efficient plus-strand DNA extension does not induce
uncoating and polymerase removal from rcDNA. Nucleocapsids
were obtained by detergent-stripping of virions from highly viremic
sera and subjected to a 16 h endogenous polymerase reaction (EPR;
+dNTP) as described [26]. (A) DHBV. After the EPR, viral DNA was
prepared via phenol extraction with or without prior PK treatment. All
of the non-treated and the indicated fractions of the PK-treated sample
were loaded on a gel and analyzed by Southern blotting. A very long
exposure plus contrast enhancement (right panel) revealed a faint band
at the dlDNA but not the rcDNA position. (B) Comparison of
electrophoretic mobility of transfection-derived and virion-derived
HBV DNA. Cytoplasmic DNA from transfected HepG2 cells and virion
DNA (prior to EPR) was treated as indicated, isolated via phenol
extraction, and analyzed by Southern blotting. Note the faster mobility
of most virion-derived DNAs, indicative of incompletely extended plus-
strands, and the virtual absence of signal without prior PK treatment.
(C) HBV EPR products. Nucleocapsids subjected to long-term EPR
conditions were treated as indicated. The shift towards the positions of
full-length rcDNA and dlDNA after the EPR indicated that the
nucleocapsid-borne polymerase was active. Nearly all DNA was resistant
towards MN. Even an overexposed autoradiogram (right panel) did not
reveal a signal without prior PK treatment.
doi:10.1371/journal.ppat.1001082.g009
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cccDNA conversion rate.
What limits the rate of HBV cccDNA formation?
Formation of cccDNA must involve nuclear transport of the
rcDNA, its release from the capsid and removal of the bound
polymerase to allow for the subsequent generation of precisely
unit-length plus-strand and minus-strand DNA and ligation of
their ends.
Regarding transport, the fraction of nuclear versus total rcDNA
was about 2-fold higher for DHBV than for HBV (Figure 4);
assuming that one cccDNA molecule originates from one
imported rcDNA molecule, and given the about equal amounts
of both species in DHBV transfected nuclei (Figure 2, 4) this ratio
increases to 4:1. Hence a lower import efficiency of HBV rcDNA
can explain only part of the lower cccDNA accumulation.
Irrespective of mechanistic details (see below), the imported
rcDNA molecules must eventually be released from the capsid to
become accessible for the late repair steps in cccDNA formation.
Nearly all of the nuclear, yet little of the cytoplasmic, full-length
HBV rcDNA was sensitive to MN (Figure 4, 5, 6), and thus no
more protected by an intact capsid shell; hence initiation of
uncoating was highly efficient. Curiously though, MN treatment
did not induce complete rcDNA degradation; instead, species with
intermediate electrophoretic mobility accumulated, suggesting the
existence of a distinct uncoating intermediate (see below). Nuclear
DHBV rcDNA, in contrast, was as resistant against MN as
cytoplasmic rcDNA, implying genome release for DHBV but not
for HBV as potentially overall rate-limiting in cccDNA formation.
Complete versus partial release from the capsid of
nuclear HBV rcDNA as one step limiting cccDNA
formation
Nuclear (save cccDNA) and cytoplasmic DNAs of both viruses
occurred in core protein associated form (Figure 5). DNA of either
virus immunoprecipitated from the cytoplasm was largely resistent
against MN, consistent with stable encapsidation. For DHBV, this
also held for the nuclear immunopellet whereas drastic differences
between cytoplasmic and nuclear fractions were revealed for
HBV. The anti-HBc antibody (a monoclonal antibody recognizing
a linear epitope exposed on intact capsids yet also on denatured
core protein; [38]) precipitated full-length rcDNA from either
fraction, yet selectively the nuclear full-length rcDNA was highly
sensitive to MN, though not over its entire length. Hence a
fraction of the HBV rcDNA in the nucleus was still associated with
core protein and this association was likely responsible for partial
nuclease protection. Together, these data indicate that the HBV
nucleocapsid structure is drastically altered upon nuclear import
such that the packaged rcDNA is at least partially exposed; the
surprisingly distinct nature of the resulting rcDNA - core protein
complexes is discussed below.
Failure of all nuclear HBV rcDNA molecules to be completely
released from core protein could have represented the major rate-
limiting step in cccDNA formation. However, about two thirds of
the nuclear full-length rcDNA could not be immunoprecipitated
(Figure 9) although the same amount of antibody precipitated
$95% of the much more abundant cytoplasmic rcDNA. Hence
partial as opposed to complete capsid release contributes to poor
HBV rcDNA to cccDNA conversion.
Polymerase protein removal from HBV rcDNA is not
overall rate-limiting
Cytoplasmic DNA of either virus not treated with PK generated
signals that were less than 10% as intense as those obtained after
artificial deproteinization (Figure 7, 8, S5, S7); even lower values
were reported by Gao and Hu [12]. We can not exclude that these
apparently protein-free DNAs are present in genuinely cytoplas-
mic nucleocapsids [26] but they could as well arise from molecules
that during work-up have been subject to fortuitous proteolysis or
leakage from ruptured nuclei, as supported by the inability of
virion-derived nucleocapsids to generate any significant amount of
protein-free rcDNA (see below). Very obvious was, in contrast, the
high proportion of protein-free HBV rcDNA in the purified
nuclei. Consistently about two thirds were recovered without PK
treatment from various samples (Figure 7, 8, S5). The low
Figure 10. Virus-specific differences between DHBV and HBV
cccDNA formation. The cartoon summarizes the steady-state levels of
different rcDNA forms in human HepG2 cells transfected with surface-
deficient viruses. They suggest specific steps that differentially affect
the rate of cccDNA formation. Cytoplasmic rcDNA of both viruses was
largely present in intact nucleocapsids, with ,10% in protein-free form.
The about four-fold higher nuclear import efficiency of DHBV vs. HBV
nucleocapsids is not considered. The red x indicates absence of intact
polymerase; the minus-strand 59 end may consist of a hydroxyl (OH) or
phosphate (encircled P) group, or still contain one or more amino acid
residues (aa) from the polymerase. (A) DHBV. Nuclei contained ,50%
rcDNA plus ,50% cccDNA. Most of the rcDNA was present in MN
resistant, i.e. bona fide intact, capsids. The fraction of protein-free
rcDNA in the nucleus (,20%) was only modestly higher than in the
cytoplasm. If stably encapsidated nuclear rcDNA is a precursor to
cccDNA (a), uncoating is the only slow step. If stable intranuclear
capsids are a dead-end product nuclear import is rate-limiting. (B) HBV.
Nuclei contained #10% MN resistant full-length rcDNA and ,5%
cccDNA; $80% of the rcDNA were MN sensitive. Hence conversion into
these forms is efficient. About one third of the sensitive rcDNA could be
precipitated with anti-HBc antibody; based on its genome region-
selective sensitivity against MN we propose this fraction to represent
partially opened capsids. About two thirds of the rcDNA was not
precipitated, consistent with complete release. Hence initiation of
uncoating is efficient but complete uncoating appears to be slow.
Roughly two thirds in either fraction were protein-free, indicating that
,40% of the nuclear HBV rcDNA were completely uncoated and no
more linked to intact polymerase. This implies a major block for HBV in
a subsequent step towards cccDNA which does not operate for DHBV.
Little if any evidence was found in support of pathway b which implies
partial uncoating and polymerase removal to occur in the cytoplasm.
doi:10.1371/journal.ppat.1001082.g010
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significant differences in the polymerase-linkage status of core
protein associated versus free rcDNA. We therefore currently
assume that a similar proportion of rcDNA molecules lacking
intact polymerase is present in either fraction (Figure 10B). Even
then, about 40% of the nuclear rcDNA were both ‘‘protein-free’’
and completely released from the capsid. If the individual nuclear
species are true precursors of one another, a major block in HBV
cccDNA formation must occur further downstream. Given the
operational definition of ‘‘protein-free’’, this could involve removal
of amino acid remnants from the polymerase from the minus-
strand 59 end, yet also (a) subsequent step(s). Defining the chemical
nature of the DNA ends in the protein-free species therefore
remains a major objective.
For DHBV, the simple model outlined as pathway b
(Figure 10A) may be valid; however, the stable encapsidation
and low degree of deproteinization (,20%) of the nuclear rcDNA
(Figure 4B, 5, 7) versus high cccDNA content are also compatible
with the existence of two kinds of capsids; one from which rcDNA
is rapidly released and efficiently converted into cccDNA such that
no stable intermediates accumulate (Figure 10A, pathway b), and
another in which uncoating is blocked or slowed down,
represented by the nuclease resistant rcDNA (Figure 10A, pathway
a). Kinetic studies will be required for a distinction. Remarkably
though, already 1990 Summers and coworkers [20] observed an
accumulation of apparently protein-free rcDNA in primary duck
hepatocytes infected with pseudotyped surface protein-deficient
DHBV and suspected this might represent an immediate
precursor to cccDNA.
Nuclear import-mediated disassembly appears to be
initiated at specific sites of the HBV nucleocapsid
The exact nature of the partially nuclease resistant HBV rcDNA
- core protein complexes in the nucleus is not yet clear; the status
of the core protein may further be probed using assembly status
dependent antibodies (for review: [39]). Conversely, however, our
characterization of the DNA in these complexes revealed several
unexpected aspects. First, although MN has non-sequence specific
endo- and exonuclease activity, MN treatment generated a
reproducible pattern (Figure 4, 7) of faster migrating DNAs, with
a sharp upper boundary at a position where double-stranded DNA
of about 2.7 kb would migrate. These species did not represent
stably encapsidated, splicing-derived shorter DNAs [32,33,40] but
rather double-stranded linear molecules lacking ,500 bp of viral
genome sequence. Most surprisingly, digestion with four different
restriction enzymes produced distinct fragments which is only
compatible with MN digestion of a defined genome region relative
to these restriction sites; accordingly, the MN sensitive region is
roughly bordered by the start of the minus-strand DNA and the
end of the core protein ORF (Figure 6). Indeed, the fifth restriction
enzyme, Bsp EI, whose single recognition site locates to this
region, did not detectably alter mobility of the MN treated DNA
although it completely linearized rcDNA. These data strongly
suggest that nuclear disassembly of the HBV nucleocapsid shell
initiates at specific sites defined by their relative position to the
packaged genome, and that these partially opened nucleocapsids
may represent a novel, transiently stable uncoating intermediate.
Implications for the mechanism of hepadnaviral genome
uncoating and deproteinization
Conceivable mechanisms for polymerase removal include
nucleolytic cleavage of a piece of rcDNA which carries the
protein, or specific cleavage of the Tyr-DNA-phosphodiester
linkage; both mechanisms, possibly coupled to proteolysis, have
been described for repair of cellular protein-DNA adducts [41];
our unpublished data (C. Ko ¨niger, M. Nassal, J. Beck) indicate
that certain Tyrosyl-DNA phosphodiesterases are indeed able to
specifically cleave the polymerase from the DNA in vitro. An
alternative model proposes that nucleocapsids themselves harbor
an intrinsic ability for polymerase removal, perhaps via capsid-
associated cellular factors, such that deproteinization as well as
partial capsid opening precede nuclear import [13,26]. Evidences
were the reported presence of substantial amounts of protein-free
and partially nuclease sensitive rcDNA in the cytoplasm, and the
formation of small amounts of protein-free DNA in DHBV
nucleocapsids derived from serum virions upon prolonged EPR
conditions.
Our results do not support this view. First, in line with results
from others [12] we found only a small fraction of the cytoplasmic
(but most of the nuclear) HBV rcDNA in protein-free form.
Second, in our hands the cytoplasmic HBV rcDNA was largely
nuclease resistant, whereas most of the nuclear rcDNA was
nuclease sensitive (Figure 4, 5). Third, we were unable to detect
protein-free rcDNA in serum-derived HBV nucleocapsids upon
prolonged EPR although the endogenous polymerase was clearly
active (Figure 9). For DHBV, the same conditions led indeed to
small amounts of protein-free DNA, as reported [26]. However,
protein removal was extremely inefficient (,0.3%), and it
concerned exclusively dlDNA, not rcDNA (Figure 9); notably,
this was also observed by the authors when they analyzed
cytoplasmic rather than virion-derived nucleocapsids [26]. While
dlDNA can be circularized by nonhomologous end joining [42],
most of the resulting molecules carry insertions or deletions,
preventing generation of functional progeny virus. Thus capsid-
autonomous deproteinization of dlDNA may exist but does not
appear to reflect a major pathway in cccDNA synthesis.
The exclusive presence and strong enrichment, respectivley, of
partially nuclease sensitive and protein-free HBV rcDNA in the
nucleus in our experiments (Figure 4, 5) strongly favors that
uncoating and polymerase removal are dependent on nuclear
import. Furthermore, the polymerase linkage of the core protein
associated MN products (Figure 7) yet overall large fraction of
protein-free rcDNA in the nucleus (Figure 7, 8) suggests that
uncoating precedes polymerase removal. Altogether, our data are
much more compatible with a nuclear import-dependent, cell
factor-mediated generation of protein-free rcDNA (Figure 10) than
with a capsid-autonomous process in the cytoplasm. This would be
in line with nuclear important-mediated alterations in capsid
properties seen in digitonin-permeabilized cells [25]. Moreover,
continued inhibition of viral polymerase activity during HBV
infection of primary tupaia hepatocytes [30] and of HepaRG cells
[43], the as yet only HBV-infectable human cell line [44], did not
prevent cccDNA formation, further supporting a dominant role
for cellular factors.
The reasons for the partially discordant results are not obvious;
cell type or cell clone specific differences are not excluded.
However, while we were able to prepare nuclei essentially free
from cytoplasmic contaminants, the reverse was not true. A more
substantial nuclear contamination of the cytoplasmic fractions
employed by Guo et al. would as well account for many of the
seeming discrepancies.
What are the determinants for virus specific regulation?
The efficient formation of DHBV cccDNA in HepG2 and
Huh7 cells demonstrates that also in these cells the underlying
pathways are principally operating; this may also hold for human
cells of non-hepatic origin, as discussed in a previous publication
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not obvious as to why conversion into cccDNA would be so much
more efficient for DHBV. One option was that the plus-strand
DNA in HBV capsids is less extended in comparison to DHBV
capsids; however, HBV rcDNA in transfection-derived capsids
from HepG2 cells was as mature as DHBV rcDNA (Figure 9).
Another option is that the cellular repair activities operate in a
sequence-specific manner because the two viruses share less than
40% sequence identity on the genome level [45]. Such sequence-
dependence remains to be explored.
Perhaps most conceivable is that viral proteins differentially
affect cccDNA formation rates, either directly or in concert with
cellular factors. Absence of the surface proteins favored nuclear
import for both viruses, yet with accumulation of cccDNA for
DHBV, and of rcDNA for HBV. Hence more complex
consequences of surface protein - core protein interactions, or an
effect of the surface proteins on cellular events affecting cccDNA
formation are not excluded. Nuclear import of rcDNA is mediated
by the viral core proteins [24]; although the DHBV genome is
even smaller than that of HBV its core protein is much larger,
including a surface-exposed domain of unknown function and a
differently organized C terminal nucleic acid binding domain [46].
Obviously, the rates of nuclear transport and the fates of the
intranuclear capsids differed between the two viruses. Even after
uncoating and polymerase removal, both proteins, or fragments
thereof, in the nucleus could affect further rcDNA processing.
Phosphorylation - dephosphorylation events in the core protein
nucleic acid binding domains are important during replication of
both viruses [33,47,48] but potentially differing consequences for
cccDNA have not yet been addressed. Not the least, mammalian
but not avian hepatitis B viruses encode an additional gene
product, HBx, whose function is still elusive [49]; however, the
ortholog from woodchuck hepatitis virus (WHV) appears to be
crucial for in vivo infection in the natural host [50,51]. If HBx was
involved in cccDNA formation, its improper expression or
functioning in the human hepatoma cells might limit HBV
cccDNA formation.
In a preliminary attempt to reveal potential regulatory activities
of gene products from one virus on cccDNA production by the
other we co-transfected HepG2 cells with the surface-deficient
variants of both viruses. HBV had little effect on nuclear DHBV
rcDNA and cccDNA formation; vice versa, HBV replication
appeared slightly reduced overall, with no enhancement of
cccDNA accumulation. In view of the multiple options for positive
and negative regulation this may not be too surprising. A more
revealing approach will therefore be coexpression of one virus with
defined individual gene products from the other.
Final conclusions
Our study identified several steps downstream of initiation of
nuclear uncoating that slow down (but do not completely prevent)
HBV rcDNA to cccDNA conversion in human hepatoma cell
lines. Because the same cells supported DHBV cccDNA formation
very well, they can not completely lack the necessary molecular
means. One option for the seeming discrepancy to efficient
cccDNA formation during HBV infection in vivo is that cellular
activities promoting the conversion are limited in these cell lines,
another that inhibitory factors are overexpressed; this seems
unlikely, though, because HBV cccDNA accumulation was not
boosted in the avian LMH cells. Still another option is that rcDNA
to cccDNA conversion is intrinsically slower for HBV than for
DHBV. Determining cccDNA copy numbers in HBV infected
human liver suffers from various experimental restrictions (see
Introduction). Hence more telling than the final yields of cccDNA
molecules per hepatocyte may be a comparison of the rates of
cccDNA accumulation in HBV versus DHBV infection. In
experimentally HBV infected chimpanzees, cccDNA levels during
the early phase increased exponentially with a doubling time of
around 4 days, expectedly paralleled by a corresponding increase
in infected hepatocytes [11]; in ducks, the doubling time was only
around 16 h [52]. These in vivo data would be compatible with
DHBV cccDNA formation occurring at a higher rate yet at this
time, a direct correlation with our findings remains speculative.
Practically, however, the accumulation in the hepatoma cells of
distinct nuclear HBV rcDNA forms that are likely intermediates in
the rcDNA to cccDNA pathway will allow to much more
thoroughly dissect the underlying molecular mechanisms. Efficient
DHBV cccDNA formation in the same cells, on the other hand,
provides a unique new tool to facilitate identification, e.g. by RNAi
technology, of the human cellular factors involved in cccDNA
biosynthesis and the screening for specific inhibitors that directly
address the form of viral genome which ensures establishment and
persistence of HBV infection.
Materials and Methods
Detailed descriptions of the plasmid constructs and procedures
employed are reported in Text S1.
Plasmid constructs
Virus vectors contained 1.56genome length sequences of HBV
(genotype D, subtype ayw; Genbank accession no.: V01460) or
DHBV (DHBV16; accession no.: K01834). Numbering for HBV
starts with the first nucleotide of the core open reading frame [53],
for DHBV with the last nucleotide of the unique Eco RI site [54].
Plasmid pCH-9/3091 [55] contains a 1.056genome of the same
HBV isolate under control of the cytomegalovirus immediate early
(CMV-IE) promoter. Surface protein deficient HBV carried
mutations at positions 1399 and 1438, introducing a stop codon
in the preS2 ORF and a Met.Thr exchange at the S ORF start.
In surface deficient DHBV, a G.A exchange at position 1165
creates a stop codon in the S ORF [56]. In the splicing-deficient
HBV construct, A1769 in the major splice acceptor consensus site
CAG|G (A1769 underlined) was changed to C.
Cell culture and transfection
HepG2, Huh7 and LMH cells were cultured essentially as
previously described [18,33]. Transfections were performed using
TransIT-LT1 reagent as recommended by the manufacturer
(Mirus). Cells were harvested 3 days post transfection, unless
indicated otherwise.
Extraction and detection of viral DNA
Briefly, cells were lysed NP40 lysis buffer, and the nuclei were
separated by low speed centrifugation [33,57]. Alternatively,
nuclei were purified by sucrose gradient sedimentation (see below).
Total cell extracts were obtained by lysis in 0.5% SDS. After
different treatments, including or not including incubation with
proteinase K (PK) and/or micrococcus nuclease (MN), viral DNAs
were isolated using QIAamp silica columns (Qiagen), or by
conventional phenol extraction as indicated. Dpn I (NEB) and
Plasmid-Safe DNase (Epicentre Biotechnologies) were applied as
suggested by the manufacturers. Viral DNAs on Southern blots
were visualized using
32P labeled full-length genome DNA probes.
Isolation of cell nuclei by sucrose gradient sedimentation
Cells were subjected to detergent lysis and subsequent sucrose
step gradient centrifugation, essentially as described [29].
Intracellular Recycling of HBV Genomes
PLoS Pathogens | www.plospathogens.org 12 September 2010 | Volume 6 | Issue 9 | e1001082Cross-contamination analysis of gradient purified nuclei
Absence of cytoplasmic contamination from the purified nuclei
was assessed by comparing the presence of cytoplasmic poly-A
binding protein (PABP) and nuclear histone H3 in total versus
nuclear extracts. Nonspecific association of viral capsids with
nuclei was addressed by mixing capsid-containing cytoplasmic
extracts from transfected cells with total lysates from untransfected
cells, followed by sucrose gradient purification of the nuclei.
Permeability of the isolated nuclei for exogenously added MN was
confirmed by fragmentation of the chromosomal DNA.
Distinction between nuclear protein-free rcDNA and
nicked cccDNA
Identity of cccDNA was confirmed by linearization upon
incubation with single-cutter restriction enzymes and resistance
against heat denaturation. RC-DNA and nicked cccDNA were
distinguished by the defined versus randomly positioned disconti-
nuites in the DNA strands. The unique recognition site for Apa LI
is located immediately upstream of the plus-strand 59 end in RC-
DNA; plus-strands not extended through this region prevent
cleavage of RC-DNA whereas randomly nicked cccDNA is not
affected. Cleavability at sites further upstream (Nco I) or
downstream (Fsp I) served as control.
Immunoprecipitation of viral nucleocapsids
For immunoprecipitation (IP) of core protein associated DNAs
monoclonal antibody 312 against HBV core protein [38] and a
polyclonal antiserum raised against recombinant DHBV capsids
[58] were used. For IPs from purified nuclei, the nuclei were
incubated in 0.756radioimmunoprecipitation (RIPA) buffer (16
RIPA buffer is 20 mM Tris (pH 7.2), 1% sodium deoxycholate,
1% Triton X-100, 0.1% sodium dodecyl sulfate, 150 mM NaCl),
and briefly sonicated; cytoplasmic extracts were adjusted to 0.756
RIPA as well. IPs were then performed as previously described
[58], with the specific antibody immobilized to protein A or
protein G Sepharose (GE Healthcare). Associated DNAs were
isolated as described above.
Endogenous polymerase reaction
Virion-derived nucleocapsids were obtained from highly
viremic sera by sedimentation in Nycodenz gradients containing
0.5% (v/v) NP-40, and subsequently incubated in EPR buffer
containing 1 mM each of the four dNTPs for 16 h, as described
[26].
Quantitation and statistical evaluation
Southern blot signal intensities were determined by phosphor-
imaging, using AIDA (Fuji) or ImageQuant software (GE
Healthcare). Background corrections were performed by subtract-
ing from the signal of interest the value obtained for an equally
sized area in the same lane. Quantitations from each blot were
performed in duplicate. In several cases, dilution series were used
to more accurately determine relative amounts of a given species
in different compartments or after different treatments. Standard
deviations were derived from at least two and mostly more
independent experiments and calculated using Microsoft Excel
software. Statistical significance was evaluated using Graphpad
Prism 5 for Mac software.
Supporting Information
Figure S1 (A) Schematic view of hepadnavirus intracellular
recycling. Upon infection, encapsidated polymerase-linked rcDNA
is transported to the nucleus and eventually converted into
cccDNA. This requires release from the capsid shell (uncoating)
and detachment from the covalently bound polymerase, plus
further steps outlined in (B). The cccDNA episome serves as
template for all viral transcripts including pgRNA. Via interaction
with the polymerase, pgRNA is packaged into viral capsids and
reverse transcribed into ssDNA of minus polarity. Due to the
protein-priming mechanism, the 59 end of the minus DNA is
covalently linked to the polymerase. Synthesis of the plus strand,
primed by an RNA oligonucleotide (dashed red extension in B)
derived from the pgRNA 59 end, yields new encapsidated rcDNA
which upon interaction of the nucleocapsid with the viral surface
proteins can be secreted in enveloped virions. Alternatively, and
particularly in the absence of the surface proteins, nuclear import
and cccDNA formation may occur again (intracellular recycling).
The dashed lines indicate poorly understood parts of the cycle.
RNA is shown in red, DNA in blue. (B) Multiple steps required
for polymerase-linked rcDNA to cccDNA conversion. Before the
final ligation to cccDNA, the protein-bound rcDNA must undergo
multiple processing steps to ensure formation of precisely unit-
length plus and minus strand DNA with ligation-compatible ends.
Found at: doi:10.1371/journal.ppat.1001082.s001 (0.12 MB PDF)
Figure S2 DHBV versus HBV replication and cccDNA
formation in human Huh7 cells. Huh7 cells were transfected with
vectors encoding wild-type and surface-deficient DHBV or HBV.
The experimental set-up was as in Figure 1 and 2. The Dpn I
digestion in the nuclear DHBV samples was less than complete yet
PsD removed most of the remaining plasmid DNA but not viral
rcDNA and cccDNA. Note the similarly efficient cccDNA
formation by the surface-deficient DHBV in Huh7 as in LMH
(Figure 1) and HepG2 cells (Figure 2). For the nuclear HBV
samples a five times longer exposure is shown to better reveal the
weak signals.
Found at: doi:10.1371/journal.ppat.1001082.s002 (1.17 MB PDF)
Figure S3 (A) Kinetics of DHBV and HBV cccDNA formation
in HepG2 cells. HepG2 cells were transfected with vectors for
surface-deficient DHBV or HBV. Cells were harvested at the
indicated day post transfection. Viral DNAs from the cytoplasm
were extracted after MN and PK treatment; nuclear DNAs were
prepared without MN but with PK treatment; the isolated nuclear
DNAs were then treated with Dpn I plus PsD. Markers (M) were
mixtures of 10 pg linear viral genomes plus 60 pg of circular
plasmids, each carrying about 500 bp of the respective virus
sequence. The panel on the right shows a four times longer
exposure of the nuclear HBV samples. Note the comparable
increases with time in nuclear rcDNA and cccDNA for both
viruses; the virus-specific pattern of high nuclear cccDNA vs.
rcDNA for DHBV and the reverse pattern for HBV did not
change. (B) Increased transcription of HBV pgRNA does not
increase cccDNA accumulation. HepG2 cells were transfected
with vectors for surface-deficient HBV in which pgRNA
transcription was either driven by the HBV core promoter
(HBV) or the cytomegalovirus immediately early promoter
(CMV). Cytoplasmic and nuclear viral DNAs were prepared as
in Figure S3A. The indicated fractions of the total cytoplasmic and
nuclear samples, obtained from one well of a 6-well plate, were
loaded. The CMV promoter controlled vector increased the levels
of replicative intermediates about 3- to 4-fold but did not induce a
detectable increase in cccDNA accumulation.
Found at: doi:10.1371/journal.ppat.1001082.s003 (1.64 MB PDF)
Figure S4 Validation of nuclei purification protocol. (A)
Distribution of cytoplasmic poly-A binding protein (PABP) and
nuclear histone H3. Cell nuclei (Nu) were prepared by sucrose
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the same cells, a total extract (To) was prepared before separation.
Samples were analyzed by Western blotting using antibodies
against PABP (kindly provided by M. Hentze, EMBL Heidelberg,
Germany) and histone H3 (Bethyl Laboratories) and chemilumi-
nescent detection. Positions of size marker proteins are indicated
on the right; *, non-specifically crossreacting band. Note that the
cytoplasmic PABP is exclusively detectable in the total lysate. (B)
Cytoplasmic viral nucleocapsids do not detectably cosediment with
nuclei. Cytoplasmic extracts (Cy) from HepG2 cells transfected
with vectors for DHBV or HBV were mixed with total lysates from
non-transfected cells. Subsequently, nuclei from the mixture were
separated by the gradient sedimentation protocol. Viral DNAs
were prepared from the cytoplasmic extracts and from the purified
nuclei by micrococcal nuclease (MN) plus proteinase K (PK)
treatment and analyzed by Southern blotting. Note the complete
absence of viral DNA from the nuclei. (C) Isolated nuclei are
permeable to exogenously added nuclease. Nuclei prepared by the
gradient sedimentation protocol were incubated for 1 h at 37uC
with the indicated amounts of micrococcal nuclease (MN). Total
DNA was prepared and analyzed by agarose gel electrophoresis
and ethidium bromide staining. The dose-dependent generation of
bands of about 0.15 kbp and multiples thereof indicates cleavage
between nucleosomes, as expected. Because a small amount of
oligomers was still visible after 1 h treatment, a 5 h incubation
time was used in experiments addressing nuclease resistance vs.
sensitivity of nuclear viral DNAs.
Found at: doi:10.1371/journal.ppat.1001082.s004 (1.08 MB PDF)
Figure S5 Characteristics of nuclear viral DNAs. (A) Evidence
that the band at the cccDNA position is truly cccDNA. Viral
DNAs from purified nuclei of HepG2 cells transfected with vectors
for surface-deficient DHBV or HBV were digested with Dpn I and
PsD. Samples were loaded without further treatment (native), after
prior incubation with Eco RI which has a single recognition site in
either viral genome (Eco RI), or after heat denaturation (denat).
Eco RI treament converted both bands into one new band
migrating at the position of double-stranded linear (DL) DNA;
heating converted the band at the rcDNA position into faster
migrating single-stranded (SS) DNA whereas the band at the
cccDNA position was not affected, as expected. The right panel
shows a longer exposure of the center panel to reveal the weak
HBV cccDNA signals. (B) Evidence that the band at the rcDNA
position is not derived from extensive nicking of cccDNA. HepG2
cells were transfected with the vector for surface-deficient HBV.
Viral DNAs were isolated from the cytoplasmic extract by
treatment with MN plus PK, or from purified nuclei either with,
or without prior PK treatment; PK treated DNA was further
incubated with Dpn I but not PsD to preserve the plasmid DNA
Dpn I fragments. Finally, the isolated DNAs were analyzed
directly (ø), or after admixing 50 pg of a DHBV plasmid and
incubation with Nco I, Apa LI, or Fsp I. MH, HBV marker
fragments; MD, linear DHBV genome. Hybridization with an
HBV specific probe (upper panels) confirmed (see Figure 3) that
about one third of the rcDNA signal was resistant to cleavage by
Apa LI but not by Nco I and Fsp I, and that this also held for
nuclear protein-free (i.e. not PK treated) rcDNA. Activity of Apa
LI was demonstrated by the absence of a Dpn I fragment
containing internal restriction sites for Apa LI and Fsp I but not
Nco I, and by the appearance of DHBV plasmid fragments of the
expected sizes (*) upon rehybridization with a DHBV specific
probe which also revealed MD (**). Due to their higher
abundance, the cytoplasmic but not the nuclear HBV signals
from the previous hybridization are still visible.
Found at: doi:10.1371/journal.ppat.1001082.s005 (3.88 MB PDF)
Figure S6 Most of the DHBV but little of the HBV full-length
rcDNA in the nucleus is resistant to nuclease. To evaluate the
intracellular distribution of nuclease resistant viral DNAs, HepG2
cells were transfected with vectors for surface-deficient DHBV (left
panel) or HBV (right panel). DNA was extracted, after prior MN
and PK treatment, from total cells or from gradient-purified
nuclei. As for the samples shown in Figure 4A which instead had
been treated with PK followed by Dpn I plus PsD, serially diluted
samples were loaded on the gel. Loading volumes are indicated in
percent of the total sample volume, obtained from one well of a 6-
well plate. For DHBV, a comparable fraction of rcDNA was
recovered from the nuclei upon either treatment (about one third;
compare the signal intensities for the 30% nuclear versus 10%
cytoplasmic aliquot), indicating the majority of nuclear rcDNA
was stably encapsidated. For HBV, in contrast, virtually no signal
for intact rcDNA was visible in the nuclear sample; instead, DNAs
with an intermediate electrophoretic mobility accumulated. The
fraction of nuclease-resistant versus total nuclear HBV rcDNA
(,10%) was estimated from experiments like that shown in
Figure 4B.
Found at: doi:10.1371/journal.ppat.1001082.s006 (0.66 MB PDF)
Figure S7 Core protein association, nuclease resistance and
polymerase linkage status of HBV rcDNA in the cytoplasm of
transfected HepG2 cells. Immunoprecipitations were performed as
in Figure 5; the relevant nuclear samples from this experiment are
shown in the right panel of Figure 5B. Note that the IP was specific
and efficient (high signal in the aHBc pellet vs. supernatant; low
signal in the mock IP pellet vs. supernatant), and that most of the
cytoplasmic rcDNA was resistant against nuclease (similarly strong
signals with vs. without MN treatment) and still linked to
polymerase (low signals without vs. with prior PK treatment). ø,
cytoplasmic lysate directly treated with MN (no IP).
Found at: doi:10.1371/journal.ppat.1001082.s007 (6.64 MB PDF)
Text S1 This file contains a detailed description of experimental
procedures not contained in the brief general Material and
Methods section of the main text, plus a list of supporting
references.
Found at: doi:10.1371/journal.ppat.1001082.s008 (0.08 MB
DOC)
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